Minneapolis, MN, May 02, 2016 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced the Company closed a private placement with net proceeds of $4,504,524. Laidlaw & Co (UK) Ltd. in New York served as the sole placement agent. The Company issued 3,003,016 common shares at a price of $1.50 per share and a half warrant with aRead more
- Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India
- Cannabis Strategic Files Provision Patent for Unique Cannabis Smoke Filtration Device
- Pura Naturals Launches New Line of Health and Beauty Products with CBD and Hemp Seed Oils
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More